Regenxbio (RGNX) Reports Q3 Loss of $1.52/Share

Regenxbio (NASDAQ: RGNX) reported Q3 EPS of ($1.52), versus ($0.73) reported last year. Revenue for the quarter came in at $1.1 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
• Alta Mesa Resources (AMR) Misses Q2 EPS by 128c